Complementation with HLA-A and HLA-D locus alleles in ankylosing spondylitis with peripheral arthritis
Kirwan, J.R.; Winska-Wiloch, H.; McCloskey, D.; Festenstein, H.
Journal of Rheumatology 14(3): 643-644
1987
ISSN/ISBN: 0315-162X PMID: 3476753 Document Number: 293189
Document emailed within 1 workday
Related Documents
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76Jaller Char, J.J.; Jaller, J.A.; Waibel, J.S.; Bhanusali, D.G.; Bhanusali, N. 2018: The Role of IL-17 in the Human Immune System and its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 17(5): 539-542
Manara, M.; Caporali, R.; Favalli, E.G.; Grosso, V.; Atzeni, F.; Sarzi Puttini, P.; Gorla, R.; Bazzani, C.; Fusaro, E.; Pellerito, R.; Rocchetta, P.A.; Sinigaglia, L. 2017: Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry Clinical and Experimental Rheumatology 35(5): 804-809
Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Dumbrăveanu, L.; Cuşnir, V.; Groppa, L.; Calinina, L. 2010: HLA B 27 uveitis in ankylosing spondylitis and reactive arthritis Oftalmologia 54(1): 29-35
Fallet, G.H.; Barnes, C.G.; Berry, H.; Mowat, A.G.; Roux, H.; Villiaumey, J. 1987: Coexisting rheumatoid arthritis and ankylosing spondylitis Journal of Rheumatology 14(6): 1135-1138
Reis, E.; Carvalho, J. 2013: Onset of rheumatoid arthritis in a patient with ankylosing spondylitis Acta Reumatologica Portuguesa 38(3): 217-219
Rantapää Dahlqvist, S.; Ström, H.; Bjelle, A.; Möller, E. 1985: HLA haplotypes in a family with ankylosing spondylitis and rheumatoid arthritis Journal of Rheumatology 12(3): 518-522
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Smith, M.D.; Gibson, R.A.; Brooks, P.M. 1985: Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis Journal of Rheumatology 12(2): 299-305
Calabro, J.J. 1977: Arthritis of the spine: early diagnosis and management of ankylosing spondylitis Medical Times 105(11): 80-96
Appel, H.; Loddenkemper, C.; Miossec, P. 2009: Rheumatoid arthritis and ankylosing spondylitis - pathology of acute inflammation Clinical and Experimental Rheumatology 27(4 Suppl 55: S15-S19
Cross, M.J.; Smith, E.U.R.; Zochling, J.; March, L.M. 2009: Differences and similarities between ankylosing spondylitis and rheumatoid arthritis: epidemiology Clinical and Experimental Rheumatology 27(4 Suppl 55: S36-S42
McCarey, D.; Sturrock, R.D. 2009: Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis Clinical and Experimental Rheumatology 27(4 Suppl 55: S124-S126
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Papagoras, C.; Voulgari, P.V.; Drosos, A.A. 2013: Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis Clinical and Experimental Rheumatology 31(4): 612-620
Sandhu, J.; Packham, J.C.; Healey, E.L.; Jordan, K.P.; Garratt, A.M.; Haywood, K.L. 2011: Evaluation of a modified arthritis self-efficacy scale for an ankylosing spondylitis UK population Clinical and Experimental Rheumatology 29(2): 223-230
Partsch, G.; Tausch, G.; Eberl, R. 1978: Plasma amino acid level in rheumatoid arthritis and ankylosing spondylitis and its variation during age Zeitschrift für Rheumatologie 37(3-4): 105-111
Kiortsis, D.N.; Mavridis, A.K.; Filippatos, T.D.; Vasakos, S.; Nikas, S.N.; Drosos, A.A. 2006: Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis Journal of Rheumatology 33(5): 921-923